Although the comorbidity rate of mild cognitive impairment associated with major depressive disorder is high, mixed results have been reported so far on the cognitive improvement induced by cholinesterase inhibitors in patients [47, 48]. This evidence concerns the gene BCHE and major depressive disorder.